BioLineRx (BLRX) Tops Q1 EPS by 11c
Tweet
Share
E-mailBioLineRx (NASDAQ: BLRX) reported Q1 EPS of ($0.01), $0.11 better than the analyst estimate of ($0.12).
For earnings history and earnings-related data on BioLineRx (BLRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- Baird Upgrades Regions Financial (RF) to Neutral
- BMO Capital Downgrades Linamar Corp (LNR:CN) (LIMAF) to Market Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
